Refine by
Respiratory Distress Syndrome Equipment & Supplies
62 equipment items found
Manufactured by:ONY Biotech based inAmherst, NEW YORK (USA)
Since its FDA approval in 1998, ONY Biotech has made tomorrow possible for so many premature babies and their families, thanks to Infasurf®(calfactant). ONY Biotech’s primary commercial product, Infasurf®(calfactant), helps prevent and treat respiratory distress syndrome in newborns, restoring surface activity in the lungs and ...
Manufactured by:Circadiance based inExport, PENNSYLVANIA (USA)
NeoPAP is a sophisticated CPAP delivery and treatment system developed to treat newborns and infants with respiratory distress syndrome (RDS) or who are recovering from RDS. ...
by:AVM Biotechnology based inSeattle, WASHINGTON (USA)
The American Lung Association describes acute respiratory distress syndrome (ARDS) as a life-threatening lung injury that allows fluid to leak into the lungs. Breathing becomes difficult and oxygen cannot get into the body. Most people who get ARDS are already at the hospital for trauma or illness. ...
Manufactured by:Avant Medical B.V. based inGeffen, NETHERLANDS
Elevated levels of ACE activity occur in serum of patients with active sarcoidosis, and occasionally in premature infants with respiratory distress syndrome, in adults with tuberculosis, leprosy and in many other pathologic conditions involving lung and liver ...
Manufactured by:Lumen Bioscience, Inc. based inSeattle, WASHINGTON (USA)
Covid-19 is widely known as a respiratory disease, but its GI symptoms are well documented. The now-famous ACE2 receptor is abundantly expressed on the cells lining the GI tract, and over half of Covid-19 sufferers show symptoms of GI distress, and up to a quarter show only GI symptoms. GI infection by the virus can have serious long-term effects, and high ...
Manufactured by:Stempeutics Research Pvt. Ltd. based inBangalore, INDIA
Stempeucel® is being developed for the treatment of Knee Osteoarthritis (OA), Diabetic Foot Ulcer (DFU), Perianal Fistula (PAF) and Acute Respiratory Distress Syndrome (ARDS) due to COVID-19 ...
Manufactured by:Merck Animal Health based inRahway, NEW JERSEY (USA)
Live vaccine for the immunization of pigs against Porcine Reproductive and Respiratory Syndrome (PRRS). Can be administered intramuscularly or intradermally with the IDAL® device. ...
Manufactured by:ImmunoPrecise Antibodies Ltd. based inVictoria, BRITISH COLUMBIA (CANADA)
Human ACE-2 (angiotensin-converting enzyme 2) belongs to the angiotensin-converting enzyme family of dipeptidyl carboxydipeptidases and has considerable homology to human angiotensin 1 converting enzyme. This secreted protein catalyzes the cleavage of angiotensin I into angiotensin 1-9, and angiotensin II into the vasodilator angiotensin 1-7. The organ- and cell-speci c expression of this gene ...
Manufactured by:Novavax based inGaithersburg, MARYLAND (USA)
Historically, we developed a vaccine candidate against MERS, a novel coronavirus first identified in 2012, as well as a vaccine candidate against SARS in 2005. In 2012, within weeks of obtaining the sequence of the circulating MERS strain, we successfully produced a vaccine candidate. Our MERS candidate was based on the major surface spike protein, which we had previously identified as the ...
Manufactured by:ImmunoPrecise Antibodies Ltd. based inVictoria, BRITISH COLUMBIA (CANADA)
Human ACE-2 (angiotensin-converting enzyme 2) belongs to the angiotensin-converting enzyme family of dipeptidyl carboxydipeptidases and has considerable homology to human angiotensin 1 converting enzyme. This secreted protein catalyzes the cleavage of angiotensin I into angiotensin 1-9, and angiotensin II into the vasodilator angiotensin 1-7. The organ- and cell-speci c expression of this gene ...
Manufactured by:Genscript based inPiscataway, NEW JERSEY (USA)
SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases. The spike protein mutation N501Y is one of six key contact residues within the receptor-binding domain (RBD) and has been identified as increasing binding affinity to human and murine ...
Manufactured by:Novavax based inGaithersburg, MARYLAND (USA)
Historically, we developed a vaccine candidate against MERS, a novel coronavirus first identified in 2012, as well as a vaccine candidate against SARS in 2005. In 2012, within weeks of obtaining the sequence of the circulating MERS strain, we successfully produced a vaccine candidate. Our MERS candidate was based on the major surface spike protein, which we had previously identified as the ...
Manufactured by:Micomme Medical Technology Development Co., Ltd. based inChangsha, CHINA
Higher Treatment pressure, more leak compensation; *AST-Premium automatic synchronization technology, excellent man-machine synchronization; *Accurate oxygen concentration control, more efficient to improve ...
Manufactured by:ATA Medical based inOrvault, FRANCE
CTMP is a transport chamber which protects the patient or the external environment from any cross contamination that could occur during land or air ...
Distributed by:MoBiTec GmbH based inGoettingen, GERMANY
COVID-19 Research: Antiviral Drug Target ? The COVID-19 pandemic is caused by infection of SARS-CoV-2 or severe acute respiratory syndrome coronavirus 2, a positive-sense single-stranded RNA virus. The RNA dependent RNA polymerase (RdRp) is a key drug target for this deadly virus. The gel-based SARS-CoV-2 RdRp assay can be used for visualization of the RNA molecules synthesized by the RNA ...
Manufactured by:Maccura Biotechnology Co., Ltd. based inChengdu, CHINA
Severe Acute Respiratory Syndrome Coronavirus 2(SARS-CoV-2) Antigen Assay Kit by Colloidal Gold ...
Manufactured by:Histocell based inDerio, SPAIN
The HC016 platform is a treatment of acute lung injury, based on mesenchymal stem cells derived from adipose tissue (ASC), improved with proprietary Histocell ...
Manufactured by:Acorda Therapeutics, Inc. based inPearl River, NEW YORK (USA)
ARCUS® is an innovative technology platform that transforms medicines into light, dry powders. These powders are designed to deliver high doses of medication through an inhalation device that is activated by a patient’s own ...
Manufactured by:Genscript based inPiscataway, NEW JERSEY (USA)
SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2), also known as 20SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2), also known as 2019-nCoV, is a positive-sense single-stranded RNA virus. It caused coronavirus disease in 2019 (COVID-19). SARS-CoV-2 contains glycosylated spike (S) protein, which is composed of S1 subunit and S2 subunit. The S1 contains a receptor-binding ...
Manufactured by:Anatolia Geneworks based inSultanbeyli – Istanbul, TURKEY
2019 Novel Coronavirus (2019-nCoV) / SARS-CoV-2, which belongs to the same family as the pathogen that causes severe acute respiratory syndrome (SARS), is first identified as the cause of a respiratory illness outbreak detected in Wuhan, China. For confirmed SARS-CoV-2 infections, symptoms can include fever, cough, and difficulty in breathing ranging from mild symptoms to severe illness and ...